These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Bupropion SR vs placebo for smoking cessation in health care professionals. Zellweger JP; Boelcskei PL; Carrozzi L; Sepper R; Sweet R; Hider AZ Am J Health Behav; 2005; 29(3):240-9. PubMed ID: 15899687 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial. Jorenby DE; Hays JT; Rigotti NA; Azoulay S; Watsky EJ; Williams KE; Billing CB; Gong J; Reeves KR; JAMA; 2006 Jul; 296(1):56-63. PubMed ID: 16820547 [TBL] [Abstract][Full Text] [Related]
9. Relationship between drug exposure and the efficacy and safety of bupropion sustained release for smoking cessation. Johnston JA; Fiedler-Kelly J; Glover ED; Sachs DP; Grasela TH; DeVeaugh-Geiss J Nicotine Tob Res; 2001 May; 3(2):131-40. PubMed ID: 11403727 [TBL] [Abstract][Full Text] [Related]
10. A randomized, controlled trial of bupropion sustained-release for preventing tobacco relapse in recovering alcoholics. Hays JT; Hurt RD; Decker PA; Croghan IT; Offord KP; Patten CA Nicotine Tob Res; 2009 Jul; 11(7):859-67. PubMed ID: 19483180 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of bupropion and predictors of successful outcome in a sample of French smokers: a randomized placebo-controlled trial. Aubin HJ; Lebargy F; Berlin I; Bidaut-Mazel C; Chemali-Hudry J; Lagrue G Addiction; 2004 Sep; 99(9):1206-18. PubMed ID: 15317642 [TBL] [Abstract][Full Text] [Related]
12. Use of sustained-release bupropion in specific patient populations for smoking cessation. Tonstad S Drugs; 2002; 62 Suppl 2():37-43. PubMed ID: 12109934 [TBL] [Abstract][Full Text] [Related]
13. Clinical efficacy of bupropion in the management of smoking cessation. Jorenby D Drugs; 2002; 62 Suppl 2():25-35. PubMed ID: 12109933 [TBL] [Abstract][Full Text] [Related]
14. Tolerability and safety of sustained-release bupropion in the management of smoking cessation. Aubin HJ Drugs; 2002; 62 Suppl 2():45-52. PubMed ID: 12109935 [TBL] [Abstract][Full Text] [Related]
15. Predictors of cessation in African American light smokers enrolled in a bupropion clinical trial. Faseru B; Nollen NL; Mayo MS; Krebill R; Choi WS; Benowitz NL; Tyndale RF; Okuyemi KS; Ahluwalia JS; Sanderson Cox L Addict Behav; 2013 Mar; 38(3):1796-803. PubMed ID: 23254230 [TBL] [Abstract][Full Text] [Related]
16. Does bupropion have advantages over other medical therapies in the cessation of smoking? Tonstad S; Johnston JA Expert Opin Pharmacother; 2004 Apr; 5(4):727-34. PubMed ID: 15102559 [TBL] [Abstract][Full Text] [Related]
17. A pilot trial of bupropion added to cognitive behavioral therapy for smoking cessation in schizophrenia. Evins AE; Mays VK; Rigotti NA; Tisdale T; Cather C; Goff DC Nicotine Tob Res; 2001 Nov; 3(4):397-403. PubMed ID: 11694208 [TBL] [Abstract][Full Text] [Related]
18. Bupropion SR for smoking cessation in smokers with cardiovascular disease: a multicentre, randomised study. Tonstad S; Farsang C; Klaene G; Lewis K; Manolis A; Perruchoud AP; Silagy C; van Spiegel PI; Astbury C; Hider A; Sweet R Eur Heart J; 2003 May; 24(10):946-55. PubMed ID: 12714026 [TBL] [Abstract][Full Text] [Related]
19. A comparison of sustained-release bupropion and placebo for smokeless tobacco cessation. Glover ED; Glover PN; Sullivan CR; Cerullo CL; Hobbs G Am J Health Behav; 2002; 26(5):386-93. PubMed ID: 12206448 [TBL] [Abstract][Full Text] [Related]
20. Pharmacogenetic clinical trial of sustained-release bupropion for smoking cessation. David SP; Brown RA; Papandonatos GD; Kahler CW; Lloyd-Richardson EE; Munafò MR; Shields PG; Lerman C; Strong D; McCaffery J; Niaura R Nicotine Tob Res; 2007 Aug; 9(8):821-33. PubMed ID: 17654295 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]